Kestra Advisory Services, LLC Biogen Inc. Transaction History

Kestra Advisory Services, LLC

$17.6 Billion
Q2 2024

A detailed history of Kestra Advisory Services, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 2,918 shares of BIIB stock, worth $507,119. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,918

Previous 2,890 0.97%

Holding current value

$507,119

Previous $623,000 8.51%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $5,334 - $6,628	28 Added 0.97%	2,918 $676,000
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $25,230 - $31,857	119 Added 4.29%	2,890 $623,000
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $25,152 - $30,277	113 Added 4.25%	2,771 $717,000
Q3 2023 Nov 09, 2023	SELL	$253.3 - $285.89 $93,974 - $106,065	-371 Reduced 12.25%	2,658 $683,000
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $206,437 - $238,545	750 Added 32.91%	3,029 $862,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $1.58 Million - $1.8 Million	-6,163 Reduced 73.0%	2,279 $633,000
Q4 2022 Jan 31, 2023	SELL	$252.44 - $306.72 $27,515 - $33,432	-109 Reduced 1.27%	8,442 $2.34 Million
Q3 2022 Nov 01, 2022	SELL	$194.69 - $268.46 $95,592 - $131,813	-491 Reduced 5.43%	8,551 $2.28 Billion
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $76,891 - $91,438	-410 Reduced 4.34%	9,042 $1.84 Million
Q1 2022 Apr 26, 2022	BUY	$193.77 - $244.14 $424,356 - $534,666	2,190 Added 30.16%	9,452 $1.99 Million
Q4 2021 Jan 20, 2022	SELL	$223.92 - $287.77 $1.09 Million - $1.41 Million	-4,888 Reduced 40.23%	7,262 $1.74 Million
Q3 2021 Oct 19, 2021	SELL	$282.99 - $369.05 $663,894 - $865,791	-2,346 Reduced 16.18%	12,150 $3.44 Million
Q2 2021 Jul 28, 2021	BUY	$259.0 - $414.71 $135,975 - $217,722	525 Added 3.76%	14,496 $5.02 Million
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $2.3 Million - $2.69 Million	9,462 Added 209.85%	13,971 $3.91 Million
Q4 2020 Jan 20, 2021	BUY	$236.26 - $355.63 $1.06 Million - $1.59 Million	4,483 Added 17242.31%	4,509 $1.1 Billion
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $6,884 - $7,948	26 New	26 $633 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Biogen Inc. Transaction History